STOP Fentanyl Act of 2021

Bill: 117-s-1457
Sponsor: Sen. Markey, Edward J. [D-MA]
Introduced: 2021-04-29 in the Senate
Policy area: Health
Subjects: American Samoa
Cardiovascular and respiratory health
Civil actions and liability
Congressional oversight
Corporate finance and management
Correctional facilities and imprisonment
Criminal investigation, prosecution, interrogation
Criminal justice information and records
Criminal procedure and sentencing
Customs enforcement
Drug safety, medical device, and laboratory regulation
Drug therapy
Drug trafficking and controlled substances
Drug, alcohol, tobacco use
Emergency medical services and trauma care
Federal preemption
Government information and archives
Government studies and investigations
HIV/AIDS
Health care costs and insurance
Health care coverage and access
Health information and medical records
Health programs administration and funding
Health promotion and preventive care
Health technology, devices, supplies
Home and outpatient care
Indian social and development programs
Infectious and parasitic diseases
Inflation and prices
Internet and video services
Internet, web applications, social media
Law enforcement administration and funding
Law enforcement officers
Manufacturing
Marketing and advertising
Medical research
Mental health
Minority health
Northern Mariana Islands
Performance measurement
Postal service
Prescription drugs
Research administration and funding
Research and development
Rural conditions and development
Smuggling and trafficking
State and local government operations
Telephone and wireless communication
Trade restrictions
U.S. territories and protectorates

Summary:
action_date: 2021-04-29
text: 

Support, Treatment, and Overdose Prevention of Fentanyl Act of 2021 or the STOP Fentanyl Act of 2021

 
This bill addresses data collection, treatment, harm reduction, and other issues related to substance misuse and addiction. It particularly focuses on opioids, fentanyl, and related substances.
 
Specifically, the bill expands surveillance of fentanyl and related substances. This includes establishing a pilot program to screen for contaminants in illicit drugs and a grant program to collect data on fentanyl-involved overdoses. The bill also specifies requirements concerning the collection and use of information about drugs seized by law enforcement.
 
Additionally, the bill establishes and modifies requirements to increase access to treatment and prevention services. For example, the Bureau of Prisons must make certain services, including medication-assisted treatments, available to individuals in its custody. The bill also
 
 
repeals a provision that requires dependence on opioids for at least one year before an individual may be admitted to certain treatment programs;
 
allows providers to prescribe medications to treat substance use disorders following a telehealth evaluation;
 
creates grant programs for treatment and harm reduction activities; and
 
addresses issues pertaining to opioid overdose reversal drugs.
 
 
Furthermore, the bill limits civil and criminal liability under specified laws for individuals who administer opioid overdose reversal drugs to an individual who reasonably appears to be experiencing an overdose, as well as for individuals who seek medical attention for themselves or on behalf of another for a drug overdose.
 
The bill also requires multiple reports, including a report by the Department of State on foreign sources of certain drugs.


Legislative actions:
action_date: 2021-04-29
text: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
action_date: 2021-04-29
text: Introduced in Senate